Top-ranked analyst Irina Koffler of Mizuho Securities initiated shares of Mylan with a buy rating on Wednesday. » Read More
Shares of Endo International surged as much as 18 percent after the company named a new CEO and projected upbeat full-year earnings.
One analyst is sticking with his pessimisitic views on Twitter, saying a potential sale does not change his concerns about the company.
Bank of America Merrill Lynch is cautious on stocks because there is little positive economic data to be found, Dan Suzuki said.
Morgan Stanley initiates coverage of Activision Blizzard and Electronic Arts with overweight ratings.
Cramer says Salesforce.com would largely benefit from acquiring Twitter, in part for its user data.
The hunt for yield has resulted in few dividend payers left to buy, except for a few "dividend orphans" that have been overlooked by investors, says Tom Lee.
Simply comparing the S&P 500's earnings growth to the 10-year Treasury yield tells you a lot about where stocks will go, according to strategist Jim Paulsen.
Twitter shares spiked more than 21 percent Friday after sources said the social media company may be moving closer to selling itself.
Jefferies reiterates its underperform rating on Netflix.
Shares of Bats Global Markets climbed in extended-hours trade after a Bloomberg report, citing sources, said CBOE Holdings was in talks to buy Bats.
Imperva gained 21 percent on Friday after a report said it has drawn acquisition interest from several companies.
Some of the names on the move ahead of the open.
Jim Cramer spoke with Laurent Potdevin about what makes Lululemon's brand unique so that it still appeals to mall customers.
Biotech stocks were trading higher Thursday afternoon and reached the highest they have been since January 2016.
Jim Cramer describes how Amazon could change how stocks are bought to let investors compete with high-frequency trading.
RBC's Mark Mahaney, one of the most followed tech analysts on Wall Street, downgraded shares of Twitter.
Get the best of CNBC in your inbox